AI in Medicine News — 2026-10-15 (Thu)

Overview

Funding and deal news was the most visible activity: Agilent's up to $270 Mn acquisition of Proscia (Digital Health News), the $38M Healthleap and $31M Vitalize raises (MedCity News, citybiz), and a $1.2bn Zealand Pharma and Generate drug discovery pact (Yahoo Finance). On regulation, the UK produced the most output: MHRA strategy and government strategy for AI regulation in healthcare (Open Access Government, Ropes & Gray LLP). In the US, ThinkTrends won a $49 Million IDIQ contract from the Food and Drug Administration (The Globe and Mail). Safety coverage included a Utah audit of health AI tools (Medical Buyer), an audit of medical model maintenance and rare diseases (Bioengineer.org), and a study of psoriasis detection in darker skin (Bioengineer.org).

Diagnostics and imaging

- A debate over AI for detecting neonatal pneumothorax was reported. The headline gives no performance figures, and the evidence stage is a debate (Bioengineer.org). - A study found AI body composition scans hold steady across CT reconstruction algorithms (Bioengineer.org). - A pocket-sized AI delivers rice disease diagnosis in under 15 milliseconds. This is plant pathology, not clinical medicine (Bioengineer.org). - Agilent will acquire Proscia for up to $270 Mn to expand AI-enabled digital pathology. This is a corporate transaction, not clinical evidence (Digital Health News, TradingView). - A study found AI struggles to spot psoriasis in darker skin. The headline gives no figures (Bioengineer.org).

Clinical decision support

- An article describes how AI supports early sepsis detection in ICU and NICU patients. The headline does not state the evidence stage (Infection Control Today). - Diagnostic Imaging asks whether AI models for breast cancer detection and risk prediction can be used interchangeably. The headline poses this as a question and gives no answer (Diagnostic Imaging). - A multicentre study confirms that AI warned of dangerous brain pressure hours before it struck. No accuracy figures are given in the headline (Bioengineer.org). - Sex-specific machine learning models predict 10-year dementia risk. The evidence stage is not stated (Neurology Advisor). - NVIDIA is backing Britain's AI safety with a US$250m push. This is funding, not a clinical finding (AI Magazine). 【Generative AI and clinical documentation】 - Northwestern Medicine embeds AI decision support inside its electronic health record (EHR). The headline gives no outcome data (Crain's Chicago Business). - Healthleap raised $38M to expand AI screening for overlooked conditions in hospitalized patients. This is financing, with no performance data in the headline (MedCity News). - The Conversation asks whether AI that can predict intimate partner violence before survivors disclose should be used. The headline frames this as an ethical question (The Conversation). - Gunma University Hospital started generative AI support for document drafting (MEDIFAX web). 【Hospital operations and care delivery】 - Vitalize raised $31M to expand its AI-powered hospital staffing platform (citybiz). - TechTarget examines whether private equity ownership affects hospital AI adoption. The headline poses this as a question (TechTarget). - VitVio is bringing its AI operating room platform Vetro to Poland in a pilot at UCK Gdańsk. The stage is a pilot (Konsulteer). - Gleneagles Hospital and TIS-H brought hospital and technology leaders together to shape responsible healthcare AI (Express Healthcare). - A Nigerian AI scientist plans to roll out MRI software in 2027 that cuts scan time by 90%. This is a plan, and the headline cites no validation (Arise News). 【Drug discovery and clinical trials】 The headlines do not state a development stage (preclinical, Phase I, etc.) for any item below. - Deep Origin and BioAge launched a multi-target AI-driven drug discovery collaboration (Contract Pharma). - Zealand Pharma signed a $1.2bn AI obesity drug discovery pact with Generate (Yahoo Finance). - AI Financial Corporation rebranded its biotech business as Drew Therapeutics, in honor of Andrew Witkoff, who succumbed to opioid addiction in 2011 (Democrat and Chronicle). - Cori Clinical raised US$4m to expand its AI platform for clinical trial design (Pharmafile). - ETF Database published an explainer on how to invest in AI drug discovery (ETF Database). 【Medical device approvals and regulation】 No headline reports an approval or clearance of a named AI device. The items are strategies, commentary and a contract. - Strategy: MHRA's 2030 Strategy plans to modernise patient-centred regulation for AI and personalised medicines (Open Access Government). - Government strategy: Ropes & Gray LLP set out ten takeaways from the UK Government's strategy for AI regulation in healthcare (Ropes & Gray LLP). - Response to the National Commission: Ropes & Gray LLP examined what the MHRA's response means for manufacturers of AI medical devices in Great Britain (Ropes & Gray LLP). - Contract: ThinkTrends landed a $49 Million IDIQ contract from the Food and Drug Administration for AI and data implementation support. This is a procurement contract, not a regulatory decision on a product (The Globe and Mail).

Safety, errors and bias

- "When AI Forgets, Rare Diseases Pay the Price": a new audit exposes hidden risks in medical model maintenance (Bioengineer.org). - Utah will audit the performance and safety of health AI tools (Medical Buyer). - A Europe-wide expert working group on AI in mental health was launched (Medical Buyer). - An article on AI in healthcare discusses prevention opportunities and the need for regulatory oversight (ShiaWaves). - The medical debt-collection ecosystem is set to change as AI takes notes (Medical Buyer). - A study found AI struggles to spot psoriasis in darker skin, a bias concern (Bioengineer.org). 【Research results (major journals)】 None of the headlines identifies a paper in a major journal. The items are opinion, projections and interviews. - The Washington Post ran an opinion piece arguing that the alarmist AI narrative about extinction potential is more than bad PR (The Washington Post). - A report says AI misuse and nuclear famine could threaten humanity's survival before 2100 (Medical Xpress). - An article says what AI gets right in medicine is giving patients time to talk (Science 2.0). - A video features Dr Soumya Swaminathan speaking to NDTV on measles resurgence, AI risks and future pandemics (NDTV). - AI powers a personalized nutrition surge, with the Korea market set to triple by 2033. This is a market projection (Chosunbiz).

Developments in Japan

- An article discusses barriers to realizing AI's potential in healthcare (mezha.net). - AI is proposing preventive healthcare programs for health insurance societies, and a system is being built for them (Nishinippon Shimbun). - Gunma University Hospital started generative AI support for document drafting (MEDIFAX web). - Directors Connect will release a free diagnostic service for talent, organization and AI use on October 14. This is a business service, not clinical (PR TIMES). - ZOZO launched a new feature combining proprietary data and AI, covering diagnosis through virtual try-on. This is fashion, not medical (AIsmiley).

Key figures' statements

No notable developments.